Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells.

Lee, Ho-June

Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells. [electronic resource] - Molecular cancer therapeutics 04 2017 - 694-704 p. digital

Publication Type: Journal Article

1538-8514

10.1158/1535-7163.MCT-16-0504 doi


Animals
Bone Neoplasms--drug therapy
Breast Neoplasms--genetics
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Checkpoint Kinase 1--genetics
DNA Damage
Deoxycytidine--administration & dosage
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Heterocyclic Compounds, 3-Ring--administration & dosage
Humans
MAP Kinase Signaling System--drug effects
Mice
Osteosarcoma--drug therapy
Ovarian Neoplasms--genetics
Piperidines--administration & dosage
Proto-Oncogene Proteins p21(ras)--genetics
Xenograft Model Antitumor Assays
Gemcitabine